Research Scientist

About Us:The Cancer Research Institute (CRI), established in 1953 and headquartered in New York City, is the preeminent U.S. nonprofit organization dedicated to saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers. Guided by a world-renowned Scientific Advisory Council that includes four Nobel laureates and 35 members of the National Academy of Sciences, CRI has invested over $517 million in support of research conducted by immunologists and tumor immunologists at the world's leading medical centers and universities and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment. The Cancer Research Institute's research funding supports the entire continuum of basic discovery through early-stage clinical development of novel cancer immunotherapies.Research ScientistThis role leads work that will have a direct impact on the field of cancer immunotherapy. The Scientific Affairs Researcher will collaborate with CRI's leadership and external stakeholders to develop, curate, and publish meaningful content to help the field at-large. The individual will stay on top of key immunotherapy trends and developments in oncology.ResponsibilitiesMonitoring the immuno-oncology drug development competitive landscape to generate new, field-wide analyses that will help guide the evolution of CRI's overall program strategies;Curating the CRI Immuno-oncology landscape database; Leading publication of the update;Collaborating with internal team members and external partners on the publication of additional research in leading academic or trade journals;Helping organize and participating in thought leadership events;Assisting in completing ad hoc consulting assignments; andAttending and reporting on scientific conferences and medical meetingsRequirementsExperience with data science tools (e.g., Python, R, SQL, or similar) is preferred but not requiredStrong interpersonal skills with the ability to work both independently and collaboratively in a teamPassionate about CRI's mission to make cancer a curable diseaseThrives in a collaborative and team-oriented environmentEager to learn, comfortable asking questions, and capable of solving complex problems proactively and autonomouslyMaintains the highest standards of professionalism and integrityDetail-oriented with strong work ethicsCollaborative, adaptable, and personable personalityComfortable working with off-site colleagues or clients using email, phone, or other remote technologiesAdvanced and current understanding of biomedical research, with preference for expertise in immunology and cancer immunology, as demonstrated by exceptional publicationsStrong analytical skills, including independent research, statistical proficiency, and expertise in tools like Excel, PowerPoint, or equivalent analytical softwareExcellent written and verbal communication skillsSelf-driven and able to excel in a hands-on, self-directed work environmentSkilled in managing timelines and handling multiple workstreams effectivelyAn advanced technical degree (PhD, MD, MPH.) in biomedical sciences or equivalent experience is required. Expertise in immunology, cancer immunotherapy or relevant cancer research fields is preferredBenefits:100% covered Health Insurance Dental & VisionLife InsuranceLong term & Short term disability 403b PlanPaid Time offWe are proud to be an equal opportunity employer, committed to fostering a diverse, inclusive, and collaborative workplace. We do not discriminate based on race, color, religion, national origin, gender, sexual orientation, age, disability, veteran status, or any other legally protected characteristic. We consider qualified applicants with criminal histories consistent with applicable laws and provide reasonable accommodations for individuals with disabilities.We offer competitive compensation and benefits tailored to factors such as location, role complexity, and experience. The estimated base salary range is $84K-94K per year.

Created: 2025-02-27